Mammary epithelial cell/clonal assay/clonogen/hormone, differentiation/susceptibility/mammary cancer We have developed an in vitro-in vivo transplantation assay for measuring the concentration of clonogenic epithelial cells in cell suspensions of rat mammary tissue. Rat mammary clonogens from organoid cultures are capable of the same degree of PLDR as clonogens in vivo. The growth and differentiation of mammary clonogens to alveolar colonies or ductal colonies is regulated as follows: a) in the presence of E2 and high prolactin (Prl), cortisol induces mammary clonogens to proliferate and differentiate to form alveolar colonies which secrete milk and begin losing clonogenic potential, b) in cortisol deficient rats, Prl and E2 synergistically stimulate non-secretory ductal colonies, formation of which retain clonogenic potential, c) E2 without pro gesterone stimulates alveolar colony formation in the presence of cortisol and high Prl, d) progesterone inhibits mammary clonogen differentiation to milk-producing cells and induces ductogenesis in a dose respon sive fashion in the presence of E2, cortisol and high Prl. High prolactin levels coupled with glucocorticoid deficiency increases the susceptibility to mammary carcinogenesis following low dose radiation exposure by increasing the number of total mammary clonogens which are the presumptive target cells and by stimulating their proliferation after exposure.
INTRODUCTION
The rat mammary clonogen transplantation assay system was designed for the study of radiogenic neoplasia at the cellular level in vivol 2) . It was postulated what radiogenic cancer arises from that subpopulation of cells which is necessary for tissue repair and repopul ation after injury or extreme physiologic stress, and that the cells which give rise on trans plantation and appropriate hormonal stimulation to clonal multicellular glandular structures are members of that subpopulation6,11) On this basis, we developed assay methods in which serial dilutions containing known numbers of monodisperesed mammary cells are inoculated into the subcutaneous fat pads of syngeneic recipients l"2). The recipient rats are hormonally manipulated to achieve high prolactin levels (Prl+) for stimulation of pro liferation and differentiation of the mammary clonogens3). Three to four weeks after transplantation, the graft sites are examined for the presence or absence of secretory spherical or ovoid alveolus-like mammary structures from the mammary clonogens4). The concentration of clonogens is then calculated from the relationship between the fraction of graft sites with one or more of these clonal glandular structures and the number of cells inoculated per site.
More recently, we have observed a second type of structure in mammary cell graft sites 5). These are non-secretory mammary ductal structures.
The following is a brief overview of the findings with these systems including results of studies of: a) establishment of in vitro in vivo transplantation assay of rat mammary clonogens; b) repair of potentially lethal damage in rat mammary clonogens in organoid culture; c) hormonal control of alveolar and ductal differentiation from mammary clonogens; and e) effects of clonogen number and proliferative state on susceptibility to carcinogenesis.
ESTABLISHMENT OF IN VITRO-IN VIVO TRANSPLANTATION ASSAY OF
RAT MAMMARY EPITHELIAL CELLS a) Alveolar colony formation and terminal dilution transplantation bioassay. The procedure have been described in detail elsewhere 1-3) and are summarized in Figure 1 . Inbred Ficher, or W/Fu rats have been used throughout. Mammary glands are removed from donor rats, minced, and enzymatically dissociated by incubation with col lagenase. The suspension containing cells, cell clumps and multicellular organoids was fractionated by filtration through a 40 µm pore filter and low speed centrifugation. The transplantation assay revealed that the fraction which contained organoids had more mam mary clonogens than the other fractions. Therefore mammary organoids have been used as the clonogen source throughout. Mammary organoids were cultured in complete hormone medium which consisted of a 1:1 mixture of Ham's F-12 medium and a-MEM supplemented with 10% fetal bovine serum, 0.5 µg/ml insulin, 0.005 µg/ml 17(3-estradiol and 0.5 µg/ml cortisol, 5 tg/ml bovine prolaction and antibiotics. After one to six days in culture, mono disperesed mammary cells were collected by trypsinization. The concentration of mono disperesed "intact" cells was determined with a phase microscope and hemocytometer, and serial dilutions were prepared. Known cell numbers were then inoculated into the inter scapular white fat pads of syngeneic recipients. The recipient rats were co-grafted with an MtT (mammotropic pituitary tumor) to serve as an indwelling source of high levels of prolactin7'8). Three weeks after mammary cell transplantation, the grafted fat pads were removed and examined for the presence or absence of AU (alveolar units) in the grafted sites. Successful grafting of mammary cells was indicated by the presence of one or more AU. AU are comprised of a sphere of mammary epithelium and accompanying myoepithelial cells surrounding a milk-filled lumen and in turn surrounded by a basement membranel,4>
The "AD50" for mammary cells, i.e. that grafted cell number which results in one or more AU in 50% of the graft sites, is calculated according to transplantation model of Porter et a19). (Fig. 2 ). The probability, p, of one or more AU per grafted site is: p = 1_e-m and logM = logK + SlogZ Where M is the number of AU-forming cells in the inoculum, K is the fraction of cells capable of AU formation, S is a constant that determines the slope of the relationship , and Z is the total number of cells inoculated10• i ). The fraction of cells surviving a given radiation exposure is then calculated as the ratio (AD50 control)/(AD50 irradiated) ( Fig. 2 ). b) Repair of potentially lethal damage in rat mammary clonogens in organoid culture . Post-irradiation intracellular repair of potentially lethal damage (PLDR) was observed in mammary clonogens left in the mammary glands in situ for 4-24 hours after exposure before removal for transplantation assay' 2). This type of PLDR affects the initial shoulder region of the survival curve; it does not significantly affect the terminal slope12). It was also been observed in thyroid 13) and hepatic 14) clonogens exposed in situ and signifi cantly exceeds the extent of repair generally seen in cells irradiated and assayed in mono layer cultures. 
HORMONAL CONTROL OF ALVEOLAR AND DUCTAL DIFFERENTIATION FROM MAMMARY CLONOGENS
The methodology developed for studies of mammary clonogens and cancer also offered an opportunity for quantitative study of the control of mammary growth and differentiation at the cellular level in vivo. As noted above, the end points in terminal dilution transplant ation assays of mammary clonogen concentrations are monoclonal multicellular alveolar units (AU) which develop in the mammary cell graft sites in intact MtT-grafted recipients . These AU are spherical, milk-filled and lined with secretory epithelium accompanied by myoepithelial cells. Ductal units (DU), clonal structures of a second type , have recently been recognized 5). DU are comprised of multibranched ducts and endbuds , and are non-secretory.
The current studies were undertaken to clarify the physiologic and/or genetic control of the formation of these two types of mammary structures with the ultimate aim of gaining information on their relationship to the genesis of mammary cancer. 
a) Glucocorticoid
The efficiency of AU and DU formation in grafts of known numbers of monodisperesed mammary epithelial cells was determined in intact young adult female F344 and W/Fu rats, cografted with MtTF416) and MtTW1015), respectively. In female F344 rats, only alveolar colony formation was observed (Fig. 4A) . In contrast, both alveolar and ductal colony formation was observed in female W/Fu rats (Fig. 4B) .
The cell dose-AU formation response curves for the two rat strains are virtually super imposable (Fig. 5 ). AU formation efficiencies are expressed in term of AD50 (alveolar dose-50%) values. The AD50 in W/Fu rats was 704 mammary cells, and in F344 rats, 786 cells (Fig. 5 ). The formation of DU was not observed in F344 rats. The DD50 in W/Fu rats calculated in the same manner as the AD50 values was 13012 cells, more than eighteen fold the AD50.
In order to determine whether the difference in formation of DU are characteristics of the grafted mammary cells or of the recipient rat strains, and if the latter, whether such differences depend on differences in the spectra of secretions of the different MtT lines, W/Fu X F344 hybrid rat experiments were designed. Results were shown in Table 1 . These results indicated that this difference in DU formation was dependent on the strain of grafted MtT, and was not a genetic characteristic of the rat strain5). MtTF4ts,16> which secretes ACTH as well as prolactin stimulated alveolar colony formation and inhibited ductal colony formation. We conclude that the high glucocorticoid levels induced in MtTF4 grafted rat promoted alveolar colony formation and inhibited ductal colony formation in grafted sites. Table 2 shows the effect of cortisol on AU and DU development in W/Fu recipients cografted with MtTW10 which does not secrete ACTH. DU formation is stimulated and AU formation is inhibited by elevation of mammotropic hormones from MtT coupled with glucocorticoid deficiency induced by adrenalectomy5). Cortisol treatment reverses this effect. Figure 6 shows the effect of adrenalectomy on the total recoverable mammary clonogens in the three inguinal mammary glands of F344 female rats 5). The total number of AU 
b) Ovarian hormones
Ovarian hormone effects on alveolar and ductal differentiation from mammary clonogens were studied with the terminal dilution transplantation system. Three recipient groups; 1) intact MtT-grafted recipients, 2) ovariectomised (Ovx) MtT-grafted recipients treated with 1 tg E2, 3) Ovx MtT-grafted recipients treated with 1 .tg E2 plus 4 mg progesterone (Prg), were prepared for this study.
The AD50 value of mammary cells grafted in E2-treated rats was not significantly dif ferent from that of cells grafted in E2 Plus Prg-treated recipients (Fig. 7A) . In contrast, the addition of Prg to E2 increased the efficiency of DU formation very markedly; in recipients treated with both Prg and E2, the DD50 was 70 fold less than in rats which received E2 alone (Fig. 7B ). Colony morphology in graft sites of E2-treated rats (Fig. 8A ) differed markedly from that in E2 Plus Prg-treated rats (Fig. 8B) when the same number of mam mary cells (9.8 x 103) were grafted into i.s. pad sites of both groups of recipients. These results show that progesterone synergizes with estrogen and/or prolactin in the induction of ductal differentiation from mammary clonogenst') . During pregnancy, the serum levels of E2, Prg, Prl (and placental lactogen), and glucocorticoid are all increased. We suggest that the increased levels of Prg present in the later stages of pregnancy serve to inhibit premature lactation and promote ductal growth. At parturition, Prg levels abruptly fall 18), estrogens, glucocorticoids and particularly Prl predominate, and lactational alveolar differentiation ensures. 
CLONOGEN NUMBERS AND PROLIFERATIVE STATE, AND CARCINOGENESIS IN SITU
As noted above, a combination of high prolactin (Prl+) coupled with glucocorticoid deficiency (Glc-) induces an increase in the total number of mammary clonogens and/or an elevation of the proliferative rate in the gland 6). It is also important to note that Prl +/ Glc is the most effective hormonal combination for promotion/progression of mammary cancer we have yet observed". Consideration of these data led to the hypothesis that, all other things being equal, radiogenic cancer incidence may be a direct function, and cancer latency an inverse function, of the number of clonogenic cells present at the time of irradiation 19, 20) To test this hypothesis, young adults female rats were exposed for 48 days to elevated Prl levels coupled with glucocorticoid deficiency (Prl+/Glc-) to increase the total number of clonogens in situ 6). Prl+/Glc for 48 days increased mammary DNA by -seven fold and tritiated thymidine incorporation into DNA by fourfold (Table 3 ). This mammary growth was accompanied by an eightfold increase in total recoverable cells and a fivefold increase in total clonogens (Table 3 ).
In rats that had Prl+ for the same period but had intact adrenals, total recoverable cells were comparably increased, but there was on change in total clonogens (Table 3 ). This latter is likely due to secretory differentiation of the clonogens under the stimulus of Prl+ combined with adrenal glucocorticoid.
When rats were irradiated with X-ray or fission neutrons one day before (day-1) or 48 days after (day+48) establishment of Prl+/Glc-, 40 cGy X-ray or 10 cGy fission neutrons on day+48 significantly increased total carcinomas per rat day at risk and reduced tumor latency as compared to unirradiated controls 6) ( Table 4 ). The same X-ray dose on day-1 before expansion of the clonogen population and increase in clonogen proliferation had no effect on tumor frequency or latency as compared to unirradiated controls. In con trast, the effects of 10 cGy neutrons given on day-1 were insignificantly different from those of the same dose on day+48 (Table 4 ). These data indicate that the carcinogenic effect of X-rays in this dose range is dependent on either or both the number and the proliferative state of the target clonogens, whereas the effect of neutrons is less so. These findings require further confirmation and extension. 
CONCLUSION
These studies of the mammary clonogens demonstrate that the terminal dilution trans plantation bioassay offers a powerful tool for the study of both the complex neoplastic process at the cellular level in vivo and hormonal control of proliferation and differentiation of mammary cells. The initiation and the promotion/progression of radiogenic mammary cancer are profoundly dependent on host hormonal conditions. Mammary cancer devel opment induced by low LET x-rays depends on either or both total clonogen numbers and proliferative state at the time of exposure; the effect of neutrons is less dependent. The target clonogenic cells are subject to hormonal control of both total population size and pathways of differentiation, and these in turn may influence some or all stages in the neoplastic process. 
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